Table 7 Multivariate analysis of clinico-pathological data and overall survival (OS) by backward stepwise variable selection (significant results only).

From: Biomarker dynamics and prognosis in breast cancer after neoadjuvant chemotherapy

 

p value

HR (95% CI)

Proliferation index Ki67

  

Low (< 30%)

 < 0.001

5.44 (CI 2.16–13.71)

High (≥ 30%)

  

cM stage

  

cM0

0.001

4.97 (CI 1.97–12.75)

cM1

  

ypT stage

  

ypT0

0.002

1.0

ypT1

 

0.05 (CI 0.01–0.34)

ypT2

 

0.04 (CI 0.01–0.24)

ypT3-4

 

0.23 (CI 0.04–1.18)